Medical Condition News

RSS

$Higher doses of Vitamin D may be most beneficial in reducing bone fractures in older adults$

Higher doses of Vitamin D may be most beneficial in reducing bone fractures in older adults

Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.

6 Jul 2012

Insight into understanding IDH mediated disease

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in cancer metabolism, announced today the publication of a new study that provides further evidence of the link between a mutated metabolic enzyme and acute myeloid leukemia (AML), one of the most common types of leukemia in adults.

6 Jul 2012

Metformin can activate neural stem cells to encourage brain repair

The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.

6 Jul 2012

Scientists discover new signalling pathway that controls both obesity and atherosclerosis

A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) and the Singapore Bioimaging Consortium (SBIC) have discovered a new signalling pathway that controls both obesity and atherosclerosis.

6 Jul 2012

The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO grant

As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.

6 Jul 2012

Diabetes on the rise among Chinese teenagers

A study led by researchers at the University of North Carolina at Chapel Hill found Chinese teenagers have a rate of diabetes nearly four times greater than their counterparts in the United States. The rise in the incidence of diabetes parallels increases in cardiovascular risk, researchers say, and is the result of a Chinese population that is growing increasingly overweight.

6 Jul 2012

Scientists use antibody injections to rapidly reverse onset of Type I diabetes in mice

Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.

6 Jul 2012

Around 7% of adults suffer from an intolerance to wine

Around seven percent of adults suffer from an intolerance to wine. This is the result of a survey presented by Peter Wigand and co-authors in the current edition of Deutsches Ärzteblatt International.

6 Jul 2012

Abbott, Sucampo receive Japanese approval for AMITIZA

Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma, Ltd., a wholly owned subsidiary of SPI, has received approval from the Ministry of Health, Labor and Welfare in Japan for AMITIZA (lubiprostone), a prescription medicine for the treatment of chronic constipation.

5 Jul 2012

Medunik Canada signs exclusive distribution agreement with Orphan Europe

Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.

5 Jul 2012

Exercise-based treatment effective in treating persistent dizziness

A professor from the University of Southampton has called on doctors around the world to give patients with persistent dizziness a booklet of simple exercises, after new research has shown that it is a very cost effective treatment for common causes of the condition.

5 Jul 2012

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin (bevacizumab - Genentech/Roche) in a preclinical model of breast cancer.

5 Jul 2012

Preventing post-operative delirium may improve recovery of cognitive ability in cardiac patients

Older patients undergoing cardiac surgery often experience changes in cognitive function, such as memory problems or an inability to focus, in the days immediately following their operations. While these changes are usually temporary, for unknown reasons, a significant number of cardiac patients will encounter long-term cognitive problems, lasting as long as a year after their surgeries.

5 Jul 2012

AIDS battle: stretching use of anti-HIV drugs

A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination therapies widely credited in the last decade for keeping the disease in check for 8 million of the 34 million infected people worldwide.

5 Jul 2012

Scientists discover constant cloud of potent inflammatory molecules surrounding the monocytes

Scientists at the University of East Anglia (UEA) have discovered a 'constant cloud' of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis.

5 Jul 2012

Study shows cells from different Parkinson’s patients have unique drug responses

Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments.

5 Jul 2012

Eltrombopag can raise blood cell levels in some people with severe aplastic anemia

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies.

5 Jul 2012

Neighboring non-cancer cells may contribute to drug resistance

One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?

5 Jul 2012

Interfascicular matrix essential for tendon function

Tendon disorders cost the UK economy more than -7bn a year and now scientists at Queen Mary, University of London have identified a vital component of tendons which could help treat them.

5 Jul 2012

Lower pH reduces ability of ASL to kill bacteria in CF airways

The human airway is a pretty inhospitable place for microbes. There are numerous immune defense mechanisms poised to kill or remove inhaled bacteria before they can cause problems. But cystic fibrosis (CF) disrupts these defenses, leaving patients particularly susceptible to airway infection, which is the major cause of disease and death in CF.

5 Jul 2012

Medical Condition News

Higher doses of Vitamin D may be most beneficial in reducing bone fractures in older adults

Insight into understanding IDH mediated disease

Metformin can activate neural stem cells to encourage brain repair

Scientists discover new signalling pathway that controls both obesity and atherosclerosis

The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO grant

Diabetes on the rise among Chinese teenagers

Scientists use antibody injections to rapidly reverse onset of Type I diabetes in mice

Around 7% of adults suffer from an intolerance to wine

Abbott, Sucampo receive Japanese approval for AMITIZA

Medunik Canada signs exclusive distribution agreement with Orphan Europe

Exercise-based treatment effective in treating persistent dizziness

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

Preventing post-operative delirium may improve recovery of cognitive ability in cardiac patients

AIDS battle: stretching use of anti-HIV drugs

Scientists discover constant cloud of potent inflammatory molecules surrounding the monocytes

Study shows cells from different Parkinson’s patients have unique drug responses

Eltrombopag can raise blood cell levels in some people with severe aplastic anemia

Neighboring non-cancer cells may contribute to drug resistance

Interfascicular matrix essential for tendon function

Lower pH reduces ability of ASL to kill bacteria in CF airways

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News